This inventor holds 2 USPTO granted patents. Top assignees: The University of Salford, Other. Active years: 2007-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lymm, GB (2007)
- Cheshire, GB (2014)
Company Filing History:
Years Active: 2007-2014
Title: Lucy Annette Hepworth: Innovator in Anticancer Compounds
Introduction
Lucy Annette Hepworth is a notable inventor based in Cheshire, GB. She has made significant contributions to the field of chemistry, particularly in the development of anticancer compounds. With a total of 2 patents, her work focuses on innovative chemical compounds that have the potential to improve cancer treatment.
Latest Patents
Hepworth's latest patents include groundbreaking work on substituted stilbenes and their reactions. These inventions relate to stilbene and quinine compounds associated with combretastatin A-4, which are utilized as anticancer compounds and prodrugs. The compounds she has developed feature various alkyl group substitutions and unique photochemical reactions that enhance their effectiveness. These reactions allow for the selective activation of the compounds at tumor sites, thereby improving their therapeutic potential.
Career Highlights
Throughout her career, Lucy Annette Hepworth has worked with esteemed institutions, including the University of Salford. Her research has contributed to advancements in the field of medicinal chemistry, particularly in the design of compounds that can be activated in specific environments, such as tumors.
Collaborations
Hepworth has collaborated with notable colleagues, including John Anthony Hadfield and Alan McGown. These partnerships have fostered a collaborative environment that has led to innovative discoveries in her field.
Conclusion
Lucy Annette Hepworth's contributions to the development of anticancer compounds highlight her role as a significant inventor in the field of chemistry. Her innovative work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile